NIBE Ltd. has secured a major contract worth $563.35 crore from the Indian Army, Ministry of Defence, for the supply of 30 sets of loiter munition systems, including 300 loiter munitions, testing equipment, and accessories. This order falls under the "Buy (Indian)" category, emphasizing the indigenous nature of the procurement. The contract is to be executed in tranches over 12 months from the advance payment date, with NIBE required to provide a 10% performance-cum-warranty bank guarantee.
This development comes amidst a broader expansion in India’s defense procurement pipeline. According to Kotak Institutional Equities, the value of Acceptance of Necessity (AoN) approvals has significantly increased, reaching $9.3 lakh crore in FY26, a substantial rise from $80,000-90,000 crore in FY21. Kotak projects this pipeline could translate into $6.5-7 lakh crore in defense orders between FY27 and FY29, potentially driving a 15% compound annual growth in order inflows.
However, the substantial FY26 AoN figure includes several large programs involving foreign platforms, such as the Multi-Role Fighter Aircraft (MRFA)/Rafale program estimated at $3.2 lakh crore. After excluding these major import-heavy programs, the underlying domestic AoN figure for FY26 moderates to around $4.5 lakh crore, suggesting that the domestic procurement cycle hasn't accelerated at the same dramatic pace as the headline number. Despite this, there's a growing focus on emerging defense technologies like loitering munitions and drones, with private sector companies like Tata Advanced Systems, L&T, Adani, and Solar Industries poised to benefit.
NIBE, an Indian defense manufacturer specializing in indigenous products like weapons systems and missile systems, views this order as a positive indicator for its growth trajectory, aligning with India's "Atmanirbhar Bharat" initiative. While investors consider such contracts as positive, analysts caution that revenue recognition occurs over time, and profitability depends on cost structures and execution. NIBE's recent financial performance has shown a decline, with revenue from operations decreasing and turning into an operating and net loss year-on-year and quarter-on-quarter. The stock fell 3.29% to $1,439.75 on the BSE following the announcement.
